Dr. James Rucker is a consultant psychiatrist currently leading the psychedelic trials group at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London. He is currently leading a randomised control trial invesitgating the safety and efficacy of the active component of magic mushrooms (psilocybin) for use in treatment resistant depression.
Interviewed by Dr. Alex Curmi - Give feedback here - thinkingmindpodcast@gmail.com - Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
SUPPORT: buymeacoffee.com/thinkingmind
Give feedback here - thinkingmindpodcast@gmail.com Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast
Published on 5 years, 1 month ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate